Beyond Conventional Autopsy: Recent Advances in Molecular Autopsy for Sudden Cardiac Death Investigation.
- 1Pathology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70124 Bari, Italy.
Abstract
Sudden cardiac death (SCD) is a leading cause of unexpected mortality worldwide and represents a major challenge in pathology, especially when conventional autopsy fails to identify a definitive cause of death. In these cases, molecular autopsy (MA) has emerged as a valuable diagnostic approach, enabling the identification of pathogenic genetic variants associated with inherited cardiomyopathies, channelopathies, and other cardiovascular diseases. This review provides a comprehensive overview of the current role of MA in the investigation of SCD, highlighting recent advances in postmortem genetic testing and their impact on forensic practice. The evolution of sequencing technologies, from targeted gene panels to whole-exome and whole-genome sequencing, as well as new long-read sequencing approaches, is discussed. Emphasis is placed on the interpretation of genetic variants according to current international guidelines, the integration of molecular findings with autopsy, histopathological, and toxicological investigations, and the importance of multidisciplinary collaboration between forensic pathologists, molecular geneticists, cardiologists, and genetic counselors. We also examine current challenges, including variants of uncertain significance, limited genotype-phenotype correlation, ethical considerations, and the need for standardized international protocols. Finally, we explore prospects, including multi-omics technologies, artificial intelligence-assisted variant interpretation, and improved data sharing initiatives, which may improve diagnostic accuracy and facilitate clinical translation. In addition to determining cause of death, MA has become an essential tool for identifying at-risk relatives through cascade screening, thus extending the role of forensic genetics from postmortem diagnosis to preventive cardiovascular medicine.
Related
- Gambling-related suicide and serious suicide attempts in the United Kingdom: a psychological autopsy and qualitative investigation
- One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
- Optoacoustic molecular signatures of muscle involvement in facioscapulohumeral dystrophy compared to conventional imaging
- Dermatophytes in Argentina: species distribution, comparative identification accuracy of conventional and proteomic methods, introduction of a novel molecular identification approach, and antifungal susceptibility profiles
- Advances and challenges in personalized cardiac modeling and simulation for predicting the risk of sudden death from malignant arrhythmias in post-myocardial infarction
BibTeX
@article{salzillo2026beyond,
title = {{Beyond Conventional Autopsy: Recent Advances in Molecular Autopsy for Sudden Cardiac Death Investigation.}},
author = {Cecilia Salzillo and Andrea Marzullo},
journal = {Genes},
year = {2026},
month = oct,
doi = {10.3390/genes17101300},
url = {https://europepmc.org/article/MED/42938416},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond Conventional Autopsy: Recent Advances in Molecular Autopsy for Sudden Cardiac Death Investigation.
AU - Cecilia Salzillo
AU - Andrea Marzullo
PY - 2026
DA - 2026/10/19
JO - Genes
DO - 10.3390/genes17101300
UR - https://europepmc.org/article/MED/42938416
AB - Sudden cardiac death (SCD) is a leading cause of unexpected mortality worldwide and represents a major challenge in pathology, especially when conventional autopsy fails to identify a definitive cause of death. In these cases, molecular autopsy (MA) has emerged as a valuable diagnostic approach, enabling the identification of pathogenic genetic variants associated with inherited cardiomyopathies, channelopathies, and other cardiovascular diseases. This review provides a comprehensive overview of the current role of MA in the investigation of SCD, highlighting recent advances in postmortem genetic testing and their impact on forensic practice. The evolution of sequencing technologies, from targeted gene panels to whole-exome and whole-genome sequencing, as well as new long-read sequencing approaches, is discussed. Emphasis is placed on the interpretation of genetic variants according to current international guidelines, the integration of molecular findings with autopsy, histopathological, and toxicological investigations, and the importance of multidisciplinary collaboration between forensic pathologists, molecular geneticists, cardiologists, and genetic counselors. We also examine current challenges, including variants of uncertain significance, limited genotype-phenotype correlation, ethical considerations, and the need for standardized international protocols. Finally, we explore prospects, including multi-omics technologies, artificial intelligence-assisted variant interpretation, and improved data sharing initiatives, which may improve diagnostic accuracy and facilitate clinical translation. In addition to determining cause of death, MA has become an essential tool for identifying at-risk relatives through cascade screening, thus extending the role of forensic genetics from postmortem diagnosis to preventive cardiovascular medicine.
SN - 2073-4425
ER -